These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 9345355

  • 1. Epidermal growth factor activates protein kinase C in the human endometrial cancer cell line HEC-1-A.
    Connor P, Talavera F, Kang JS, Burke J, Roberts J, Menon KM.
    Gynecol Oncol; 1997 Oct; 67(1):46-50. PubMed ID: 9345355
    [Abstract] [Full Text] [Related]

  • 2. Mitogenic activity of growth factors in the human endometrial adenocarcinoma cell lines HEC-1-A and KLE.
    Pearl ML, Talavera F, Gretz HF, Roberts JA, Menon KM.
    Gynecol Oncol; 1993 Jun; 49(3):325-32. PubMed ID: 8314534
    [Abstract] [Full Text] [Related]

  • 3. Protein kinase C-dependent and -independent pathways mediate epidermal growth factor (EGF) effects in human endometrial adenocarcinoma cell line KLE.
    Gretz HF, Talavera F, Connor P, Pearl M, Lelle RJ, Roberts JA, Menon KM.
    Gynecol Oncol; 1994 May; 53(2):228-33. PubMed ID: 8188084
    [Abstract] [Full Text] [Related]

  • 4. Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines.
    Putz T, Culig Z, Eder IE, Nessler-Menardi C, Bartsch G, Grunicke H, Uberall F, Klocker H.
    Cancer Res; 1999 Jan 01; 59(1):227-33. PubMed ID: 9892211
    [Abstract] [Full Text] [Related]

  • 5. Transforming growth factor-alpha and insulin-like growth factor-I, but not epidermal growth factor, elicit autocrine stimulation of mitogenesis in endometrial cancer cell lines.
    Reynolds RK, Hu C, Baker VV.
    Gynecol Oncol; 1998 Aug 01; 70(2):202-9. PubMed ID: 9740691
    [Abstract] [Full Text] [Related]

  • 6. Regulation of PTP1D mRNA by peptide growth factors in the human endometrial cell line HEC-1-A.
    Burke JJ, Talavera F, Menon KM.
    J Soc Gynecol Investig; 1997 Aug 01; 4(6):310-5. PubMed ID: 9408887
    [Abstract] [Full Text] [Related]

  • 7. Protein kinase C inhibits epidermal growth factor receptor phosphorylation in enterocytes.
    Summers ST, Bass BL.
    J Surg Res; 1997 Apr 01; 69(1):208-11. PubMed ID: 9202672
    [Abstract] [Full Text] [Related]

  • 8. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways.
    Tuck AB, Hota C, Wilson SM, Chambers AF.
    Oncogene; 2003 Feb 27; 22(8):1198-205. PubMed ID: 12606946
    [Abstract] [Full Text] [Related]

  • 9. Transforming growth factor-beta negatively modulates proliferation and c-fos expression of the human endometrial adenocarcinoma cell line HEC-1-A.
    Bergman CA, Talavera F, Christman GM, Baker VV, Roberts JA, Menon KM.
    Gynecol Oncol; 1997 Apr 27; 65(1):63-8. PubMed ID: 9103392
    [Abstract] [Full Text] [Related]

  • 10. Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells.
    Greco S, Muscella A, Elia MG, Romano S, Storelli C, Marsigliante S.
    J Cell Physiol; 2004 Oct 27; 201(1):84-96. PubMed ID: 15281091
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin II activates extracellular signal regulated kinases via protein kinase C and epidermal growth factor receptor in breast cancer cells.
    Greco S, Muscella A, Elia MG, Salvatore P, Storelli C, Mazzotta A, Manca C, Marsigliante S.
    J Cell Physiol; 2003 Aug 27; 196(2):370-7. PubMed ID: 12811831
    [Abstract] [Full Text] [Related]

  • 12. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells.
    Johnson FM, Saigal B, Donato NJ.
    J Cell Physiol; 2005 Nov 27; 205(2):218-27. PubMed ID: 15887238
    [Abstract] [Full Text] [Related]

  • 13. Formation of distinct signalling complexes involving phosphatidylinositol 3-kinase activity with stimulation of epidermal growth factor or insulin-like growth factor-I in human skin fibroblasts.
    Takahashi Y, Akanuma Y, Yazaki Y, Kadowaki T.
    J Cell Physiol; 1999 Jan 27; 178(1):69-75. PubMed ID: 9886492
    [Abstract] [Full Text] [Related]

  • 14. EGF-induced ERK phosphorylation independent of PKC isozymes in human corneal epithelial cells.
    Xu KP, Dartt DA, Yu FS.
    Invest Ophthalmol Vis Sci; 2002 Dec 27; 43(12):3673-9. PubMed ID: 12454035
    [Abstract] [Full Text] [Related]

  • 15. Activation of protein kinase C and specific phosphorylation of a Mr 90,000 membrane protein of promotable BALB/3T3 and C3H/10T1/2 cells by tumor promoters.
    Chida K, Hashiba H, Sasaki K, Kuroki T.
    Cancer Res; 1986 Mar 27; 46(3):1055-62. PubMed ID: 3080229
    [Abstract] [Full Text] [Related]

  • 16. Fatty acid modulation of epidermal growth factor-induced mouse mammary epithelial cell proliferation in vitro.
    Sylvester PW, Birkenfeld HP, Hosick HL, Briski KP.
    Exp Cell Res; 1994 Sep 27; 214(1):145-53. PubMed ID: 8082717
    [Abstract] [Full Text] [Related]

  • 17. Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration.
    Cui X, Kim HJ, Kuiatse I, Kim H, Brown PH, Lee AV.
    Cancer Res; 2006 May 15; 66(10):5304-13. PubMed ID: 16707456
    [Abstract] [Full Text] [Related]

  • 18. Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein alpha(I)-mediated activation of phosphotyrosine phosphatase.
    Gründker C, Völker P, Emons G.
    Endocrinology; 2001 Jun 15; 142(6):2369-80. PubMed ID: 11356684
    [Abstract] [Full Text] [Related]

  • 19. GnRH-II agonist [D-Lys6]GnRH-II inhibits the EGF-induced mitogenic signal transduction in human endometrial and ovarian cancer cells.
    Eicke N, Günthert AR, Emons G, Gründker C.
    Int J Oncol; 2006 Nov 15; 29(5):1223-9. PubMed ID: 17016655
    [Abstract] [Full Text] [Related]

  • 20. The protein kinase C inhibitor Go6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] potentiates agonist-induced mitogen-activated protein kinase activation through tyrosine phosphorylation of the epidermal growth factor receptor.
    Shah BH, Olivares-Reyes JA, Catt KJ.
    Mol Pharmacol; 2005 Jan 15; 67(1):184-94. PubMed ID: 15465928
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.